IONKF - CBD Company Receives Joint Warning Letter from FTC and FDA
This Tuesday, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) posted a joint warning letter to CBD company Rooted Apothecary LLC. The letter cautioned the Naples, Florida-based company against illegally selling CBD-infused products, and making unsubstantiated claims that their products could treat teething pain and earaches in infants, ADHD, Parkinson’s, Alzheimer’s and a host of other diseases.
CBD has been a subject of controversy for the past few years. Tons of people swear that the compound gave them relief from a variety of medical conditions, but there is very little scientific research and evidence to prove this. Furthermore, cannabidiol is derived from the cannabis plant, most famous for the psychotropic high users experience after using it. Last year’s Farm Bill allowed the farming of cannabis, but only if there’s less than...
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.